Underscoring the complexity of DMG biology, residual PRC2 activity has been shown to be essential for tumor growth through H3K27me3 retention and subsequent transcriptional repression of critical tumor suppressors such as CDKN2A (Chan et al., 2013; Mohammad et al., 2017). The gene discussed is CDKN2A; the disease is neoplasm.